PPI inhibitors
Solezol

Solezol is indicated in adult for: :

• Gastroesophageal reflux disease (GERD) in patients with esophagitis and/or severe symptoms of reflux as an alternative to oral therapy when oral intake is not appropriate.

• Prevention of rebleeding following therapeutic endoscopy for acute bleeding gastric or duodenal ulcers. Solezol is indicated in children and adolescents aged 1-18 years for:

• Gastric antisecretory treatment when the oral route is not possible, such as: gastroesophageal reflux disease (GERD) in patients with erosive reflux esophagitis and/or severe symptoms of reflux.

For more information
solezol

Other Products

Accessibility Toolbar